ORIONINFU Stock Overview
Orion Infusion Limited engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Orion Infusion Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳568.20 |
| 52 Week High | ৳726.90 |
| 52 Week Low | ৳284.20 |
| Beta | -1.72 |
| 1 Month Change | 11.76% |
| 3 Month Change | 17.49% |
| 1 Year Change | 58.32% |
| 3 Year Change | 688.07% |
| 5 Year Change | 956.13% |
| Change since IPO | 4,635.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| ORIONINFU | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | 11.6% | -2.0% | -2.3% |
| 1Y | 58.3% | -14.8% | -17.4% |
Return vs Industry: ORIONINFU exceeded the BD Pharmaceuticals industry which returned -14.8% over the past year.
Return vs Market: ORIONINFU exceeded the BD Market which returned -17.4% over the past year.
Price Volatility
| ORIONINFU volatility | |
|---|---|
| ORIONINFU Average Weekly Movement | 9.2% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in BD Market | 8.7% |
| 10% least volatile stocks in BD Market | 3.4% |
Stable Share Price: ORIONINFU has not had significant price volatility in the past 3 months.
Volatility Over Time: ORIONINFU's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 764 | Salman Karim | www.orioninfusion.com |
Orion Infusion Limited engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh. It offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; Metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd.
Orion Infusion Limited Fundamentals Summary
| ORIONINFU fundamental statistics | |
|---|---|
| Market cap | ৳11.57b |
| Earnings (TTM) | ৳42.65m |
| Revenue (TTM) | ৳824.75m |
271.2x
P/E Ratio14.0x
P/S RatioIs ORIONINFU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORIONINFU income statement (TTM) | |
|---|---|
| Revenue | ৳824.75m |
| Cost of Revenue | ৳493.82m |
| Gross Profit | ৳330.93m |
| Other Expenses | ৳288.28m |
| Earnings | ৳42.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.09 |
| Gross Margin | 40.12% |
| Net Profit Margin | 5.17% |
| Debt/Equity Ratio | 110.1% |
How did ORIONINFU perform over the long term?
See historical performance and comparison